We do realize that identifying psychosis in a defined area of community, then advising treatment for them, to follow them up at their place of stay, to study adherence through tablet counts and confirmation through electronic devices, monitoring serum drug levels and using validated instruments for noncompliance or validate the proposed instrument would have added to the strength of the study. In future, e-pharmacy and e-follow-up may change the dynamics of compliance. Currently, we have used clinic-based population but care was taken to define compliance based on operational definition as per the literature and select the cases which fulfilled the inclusion criteria.
At the most, points of deficiencies in the study are limitations of the study which have been acknowledged by us in the article and does not warrant rejection of the findings lock stock and barrel. We do realize compliance is a complex and dynamic issue. We have tried to chisel pebbles out of a complex rock of compliance.
The strength of the study lies in (1) a fairly large sample, (2) sample which is drawn from different treatment settings, (3) construction of a scale of factors of compliance and noncompliance based on literature and provisions for an open ended question to allow for extra questions, (4) classifying factors according to domains, and (5) extraction of factors from both compliant group and noncompliant group simultaneously.
Some important findings not reported in earlier studies are; comorbidity of physical illness being a factor in treatment compliance of psychiatric patients, importance of treatment by proxy, role of remission of symptom contributing to compliance and noncompliance needing proper psych education, domain differences in groups of compliance and noncompliance, and suggestions to psychiatrists about some measures to improve compliance based on the study findings.
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patients. However, there are reasons to reconsider the conclusions that the authors have drawn from their study.
Assuming that the authors recruited 50 consecutive patients (as they should have if they followed good sampling procedures), the data that the authors presented in Table 1 in their paper look too good to be true. There were exactly 25 patients in Sir,
Singh et al. [1] administered the Wisconsin Card Sorting Test (WCST) to patients with positive and negative symptom schizophrenia, classified based on their composite Positive and Negative Syndrome Scale score. They reported distinct WCST measure deficits in positive and negative schizophrenia each group, and the groups were almost perfectly matched on not one but three continuous variables, all of which showed a distinct leptokurtic distribution. Furthermore, the age at illness onset plus duration of illness should yield present age, and this was not so in the data shown in Table 1 , again strongly suggesting that the data are suspect.
In addition, in Table 1 , for example, the F values for the age of onset and duration of illness are both wrong. F values are wrong in other tables, too. As can be inferred from Table 2 in their paper, the composite score for positive symptom patients is wrongly calculated. In Table 3 , the degrees of freedom are stated as 2.7 for all variables; this makes no sense at all for a one-way analysis of variance. In Table 3 , there could be an error in the data for total number of errors and percent errors; these values are not in parallel, as in the case of the other related variables.
There are other shortcomings in the study and in the results presented. It is not clear whether Institutional Ethics Committee approval for the study was obtained. A final curiosity is that none of the authors report an affiliation with the site at which the study was conducted. The authors of the study should make available their raw data for scrutiny and submit appropriate corrections to this paper before the results, and its implications can be considered.
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